Does the combination of simvastatin with amlodipine increase the risk of myopathy?

    loading  Checking for direct PDF access through Ovid

Abstract

Evidence-Based Answer

Pharmacokinetic analyses demonstrate an increase in simvastatin drug concentrations when administered concurrently with amlodipine. It is unclear to what extent this effect increases the risk of myopathy (SOR: C, disease-oriented evidence).

Related Topics

    loading  Loading Related Articles